CompletedPhase 4NCT02188576
The Efficacy and Population Pharmacokinetics of Tranexamic Acid for Craniosynostosis Surgery
Studying Craniosynostosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Children's Hospital
- Principal Investigator
- Susan Goobie, MD, MDBoston Children's Hospital
- Intervention
- high dose TXA(drug)
- Enrollment
- 66 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2014 – 2018
Study locations (1)
- Boston Children's Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02188576 on ClinicalTrials.govOther trials for Craniosynostosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06928727Ocular Characteristics in Patients With CraniosynostosisCentre Hospitalier Universitaire, Amiens
- ENROLLING BY INVITATIONNANCT05911139Influence of General Anesthesia on the Dynamic Changes in Brain Damage Markers During and After Craniosynostosis Operations in InfancyComenius University
- ACTIVE NOT RECRUITINGNCT03025763Network Of Clinical Research Studies On Craniosynostosis, Skull Malformations With Premature Fusion Of Skull BonesIcahn School of Medicine at Mount Sinai
- ACTIVE NOT RECRUITINGPHASE2NCT02229968Efficacy of Amicar for Children Having Craniofacial SurgeryChildren's National Research Institute